Skip to main content
. 2020 Aug 4;324(5):471–480. doi: 10.1001/jama.2020.10224

Table 2. Adjusted Mean Scores for the 8-Item Patient Health Questionnaire Depression Scale (PHQ-8) at Each Year Since Randomization Compared With Baseline.

Vitamin D3 Placebo Between-group difference for mean change in PHQ-8 score (95% CI)b P value P for interactionc
No. of participants Adjusted mean PHQ-8 score (95% CI)a No. of participants Adjusted mean PHQ-8 score (95% CI)a
At baseline 9181 1.08 (1.05 to 1.11) 9172 1.13 (1.09 to 1.16)
1 y vs baseline 8534 0.03 (−0.01 to 0.07) 8486 0.03 (0 to 0.07) −0.01 (−0.06 to 0.05) .84 .71
2 y vs baseline 8381 0.07 (0.03 to 0.11) 8344 0.04 (0 to 0.08) 0.03 (−0.03 to 0.08) .35
3 y vs baseline 8176 0.09 (0.05 to 0.13) 8112 0.07 (0.03 to 0.12) 0.01 (−0.04 to 0.07) .63
4 y vs baseline 7763 0.06 (0.02 to 0.10) 7603 0.07 (0.03 to 0.11) −0.01 (−0.07 to 0.05) .73
5 y vs baseline 5316 0.20 (0.15 to 0.25) 5231 0.16 (0.11 to 0.22) 0.03 (−0.04 to 0.10) .40
Overall 9181 9172 0.01 (−0.04 to 0.05)d .72
a

From general linear models of response profiles to estimate the means, with time modeled as indicator variables; models were controlled for age, sex, and fish oil randomization group. The repeated-measures model used all available responses and can handle missing outcome data, which were assumed to be missing at random.

b

From the repeated-measures model (primary outcome).

c

Calculated using 5 degrees of freedom for the treatment × time interaction term in the model.

d

Averaged across all follow-up years (1-5 years) from the repeated-measures model; all participants contributed data to the repeated-measures analysis at 1 or more times.